195 related articles for article (PubMed ID: 26179333)
21. SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer.
Wang F; Ma YL; Zhang P; Shen TY; Shi CZ; Yang YZ; Moyer MP; Zhang HZ; Chen HQ; Liang Y; Qin HL
J Pathol; 2013 Jan; 229(1):12-24. PubMed ID: 22821729
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer.
Zhang Y; Wang X; Xu B; Wang B; Wang Z; Liang Y; Zhou J; Hu J; Jiang B
Oncol Rep; 2013 Oct; 30(4):1976-84. PubMed ID: 23900443
[TBL] [Abstract][Full Text] [Related]
23. miR-10a suppresses colorectal cancer metastasis by modulating the epithelial-to-mesenchymal transition and anoikis.
Liu Y; Zhang Y; Wu H; Li Y; Zhang Y; Liu M; Li X; Tang H
Cell Death Dis; 2017 Apr; 8(4):e2739. PubMed ID: 28383561
[TBL] [Abstract][Full Text] [Related]
24. miR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment.
Liu S; Tetzlaff MT; Wang T; Yang R; Xie L; Zhang G; Krepler C; Xiao M; Beqiri M; Xu W; Karakousis G; Schuchter L; Amaravadi RK; Xu W; Wei Z; Herlyn M; Yao Y; Zhang L; Wang Y; Zhang L; Xu X
Pigment Cell Melanoma Res; 2015 Jul; 28(4):431-41. PubMed ID: 25903073
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic regulation of microRNA expression in colorectal cancer.
Bandres E; Agirre X; Bitarte N; Ramirez N; Zarate R; Roman-Gomez J; Prosper F; Garcia-Foncillas J
Int J Cancer; 2009 Dec; 125(11):2737-43. PubMed ID: 19521961
[TBL] [Abstract][Full Text] [Related]
26. Identification of novel small compounds that restore E-cadherin expression and inhibit tumor cell motility and invasiveness.
Hirano T; Satow R; Kato A; Tamura M; Murayama Y; Saya H; Kojima H; Nagano T; Okabe T; Fukami K
Biochem Pharmacol; 2013 Nov; 86(10):1419-29. PubMed ID: 24035834
[TBL] [Abstract][Full Text] [Related]
27. Combination of azacytidine and curcumin is a potential alternative in decitabine-resistant colorectal cancer cells with attenuated deoxycytidine kinase.
Hosokawa M; Seiki R; Iwakawa S; Ogawara KI
Biochem Biophys Res Commun; 2021 Nov; 578():157-162. PubMed ID: 34571370
[TBL] [Abstract][Full Text] [Related]
28. Angiopoietin-like protein 2 negatively regulated by microRNA-25 contributes to the malignant progression of colorectal cancer.
Zhou J; Wang J; Wu S; Zhu S; Wang S; Zhou H; Tian X; Tang N; Nie S
Int J Mol Med; 2014 Nov; 34(5):1286-92. PubMed ID: 25174582
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-200c overexpression plays an inhibitory role in human pancreatic cancer stem cells by regulating epithelial-mesenchymal transition.
Ma C; Ding YC; Yu W; Wang Q; Meng B; Huang T
Minerva Med; 2015 Aug; 106(4):193-202. PubMed ID: 26081037
[TBL] [Abstract][Full Text] [Related]
30. MSC-Derived exosomes suppress colorectal cancer cell proliferation and metastasis via miR-100/mTOR/miR-143 pathway.
Jahangiri B; Khalaj-Kondori M; Asadollahi E; Purrafee Dizaj L; Sadeghizadeh M
Int J Pharm; 2022 Nov; 627():122214. PubMed ID: 36152993
[TBL] [Abstract][Full Text] [Related]
31. Prostate carcinoma cell-derived exosomal MicroRNA-26a modulates the metastasis and tumor growth of prostate carcinoma.
Wang X; Wang X; Zhu Z; Li W; Yu G; Jia Z; Wang X
Biomed Pharmacother; 2019 Sep; 117():109109. PubMed ID: 31229922
[TBL] [Abstract][Full Text] [Related]
32. Regulation of colorectal carcinoma stemness, growth, and metastasis by an miR-200c-Sox2-negative feedback loop mechanism.
Lu YX; Yuan L; Xue XL; Zhou M; Liu Y; Zhang C; Li JP; Zheng L; Hong M; Li XN
Clin Cancer Res; 2014 May; 20(10):2631-42. PubMed ID: 24658157
[TBL] [Abstract][Full Text] [Related]
33. EVs delivery of miR-1915-3p improves the chemotherapeutic efficacy of oxaliplatin in colorectal cancer.
Xiao Z; Liu Y; Li Q; Liu Q; Liu Y; Luo Y; Wei S
Cancer Chemother Pharmacol; 2021 Dec; 88(6):1021-1031. PubMed ID: 34599680
[TBL] [Abstract][Full Text] [Related]
34. Core 3 mucin-type O-glycan restoration in colorectal cancer cells promotes MUC1/p53/miR-200c-dependent epithelial identity.
Ye J; Wei X; Shang Y; Pan Q; Yang M; Tian Y; He Y; Peng Z; Chen L; Chen W; Wang R
Oncogene; 2017 Nov; 36(46):6391-6407. PubMed ID: 28745318
[TBL] [Abstract][Full Text] [Related]
35. Pleiotropic actions of miR-21 highlight the critical role of deregulated stromal microRNAs during colorectal cancer progression.
Bullock MD; Pickard KM; Nielsen BS; Sayan AE; Jenei V; Mellone M; Mitter R; Primrose JN; Thomas GJ; Packham GK; Mirnezami AH
Cell Death Dis; 2013 Jun; 4(6):e684. PubMed ID: 23788041
[TBL] [Abstract][Full Text] [Related]
36. [Effect and mechanism of DNMT inhibitor on the reversal of multidrug resistance in human colon cancer cell line sw620/L-OHP].
Deng Q; Li ZP; Huang CM; Liu Z; Zhong RM; Li AJ; Bi F; Tang QL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Nov; 41(6):975-9. PubMed ID: 21265097
[TBL] [Abstract][Full Text] [Related]
37. Exosomal miR-224-5p from Colorectal Cancer Cells Promotes Malignant Transformation of Human Normal Colon Epithelial Cells by Promoting Cell Proliferation through Downregulation of CMTM4.
Wu F; Yang J; Shang G; Zhang Z; Niu S; Liu Y; Liu H; Jing J; Fang Y
Oxid Med Cell Longev; 2022; 2022():5983629. PubMed ID: 35814269
[TBL] [Abstract][Full Text] [Related]
38. MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine.
Xiang Y; Ma N; Wang D; Zhang Y; Zhou J; Wu G; Zhao R; Huang H; Wang X; Qiao Y; Li F; Han D; Wang L; Zhang G; Gao X
Oncogene; 2014 Jan; 33(3):378-86. PubMed ID: 23318422
[TBL] [Abstract][Full Text] [Related]
39. Hsa-miR-19a is associated with lymph metastasis and mediates the TNF-α induced epithelial-to-mesenchymal transition in colorectal cancer.
Huang L; Wang X; Wen C; Yang X; Song M; Chen J; Wang C; Zhang B; Wang L; Iwamoto A; Wang J; Liu H
Sci Rep; 2015 Aug; 5():13350. PubMed ID: 26302825
[TBL] [Abstract][Full Text] [Related]
40. miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression.
Tang H; Deng M; Tang Y; Xie X; Guo J; Kong Y; Ye F; Su Q; Xie X
Clin Cancer Res; 2013 Oct; 19(20):5602-12. PubMed ID: 23995857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
